{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:06:02Z","timestamp":1794013562659,"version":"4.8.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1053\/j.gastro.2026.04.008","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:24:35Z","timestamp":1777490675000},"page":"504-520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Recommendations for the Evaluation and Management of Inflammatory Bowel Disease With Irritable Bowel Syndrome\u2013Like Symptoms: A Joint Rome Foundation and International Organization for the Study of IBD (IOIBD) Consensus"],"prefix":"10.1053","volume":"171","author":[{"given":"Christopher","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander C.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana G.","family":"Hashash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Barbara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles N.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren M.","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Keefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Millie D.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Nurko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce E.","family":"Sands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2026.04.008_bib1","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S2468-1253(20)30300-9","article-title":"Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis","volume":"5","author":"Fairbrass","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.04.008_bib2","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2016.02.031","article-title":"Bowel disorders","volume":"150","author":"Lacy","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.04.008_bib3","article-title":"Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019","volume":"13","author":"Wang","year":"2023","journal-title":"BMJ Open"},{"key":"10.1053\/j.gastro.2026.04.008_bib4","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/MCG.0000000000001391","article-title":"Dose augmentation of tumor necrosis factor inhibitors is frequently performed in persons with inflammatory bowel disease in the absence of objective evidence of active inflammation","volume":"55","author":"Elias","year":"2021","journal-title":"J Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2026.04.008_bib5","first-page":"228","article-title":"Rome Foundation Working Team Report on overlap in disorders of gut-brain interaction","volume":"22","author":"Barbara","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.04.008_bib6","series-title":"RAND\/UCLA appropriateness method user's manual","author":"Fitch","year":"2000"},{"key":"10.1053\/j.gastro.2026.04.008_bib7","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2026.04.008_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/gut.43.1.29","article-title":"A simple clinical colitis activity index","volume":"43","author":"Walmsley","year":"1998","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2026.04.008_bib9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.cgh.2010.01.001","article-title":"Correlation between the Crohn's disease activity and Harvey-Bradshaw indices in assessing Crohn's disease severity","volume":"8","author":"Vermeire","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.04.008_bib10","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/00005176-199904001-00003","article-title":"Development and subsequent refinement of the inflammatory bowel disease questionnaire: a quality-of-life instrument for adult patients with inflammatory bowel disease","volume":"28","author":"Irvine","year":"1999","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1053\/j.gastro.2026.04.008_bib11","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study","volume":"70","author":"Best","year":"1976","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.04.008_bib12","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/01.MIB.0000215091.77492.2a","article-title":"Predicting the Crohn's disease activity index from the Harvey-Bradshaw Index","volume":"12","author":"Best","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2026.04.008_bib13","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1097\/MCG.0b013e31828b2196","article-title":"Development of the patient Harvey Bradshaw index and a comparison with a clinician-based Harvey Bradshaw index assessment of Crohn's disease activity","volume":"47","author":"Bennebroek Evertsz","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2026.04.008_bib14","first-page":"557","article-title":"The IMPACT questionnaire: a valid measure of health-related quality of life in pediatric inflammatory bowel disease","volume":"35","author":"Otley","year":"2002","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1053\/j.gastro.2026.04.008_bib15","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1053\/j.gastro.2007.05.029","article-title":"Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study","volume":"133","author":"Turner","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.04.008_bib16","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1053\/j.gastro.2022.12.006","article-title":"Development and validation of the TUMMY-UC: a patient-reported outcome for pediatric ulcerative colitis","volume":"164","author":"Marcovitch","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.04.008_bib17","first-page":"439","article-title":"Development and validation of a pediatric Crohn's disease activity index","volume":"12","author":"Hyams","year":"1991","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1053\/j.gastro.2026.04.008_bib18","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/ibd\/izae060","article-title":"Operating properties of disease activity indices in pediatric inflammatory bowel disease: a systematic review","volume":"31","author":"Colman","year":"2025","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2026.04.008_bib19","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1038\/ajg.2014.237","article-title":"Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) gastrointestinal symptom scales","volume":"109","author":"Spiegel","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.04.008_bib20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"10.1053\/j.gastro.2026.04.008_bib21","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.gastro.2026.04.008_bib22","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1023\/A:1018831127942","article-title":"Quality of life in persons with irritable bowel syndrome: development and validation of a new measure","volume":"43","author":"Patrick","year":"1998","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2026.04.008_bib23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2036.2004.02007.x","article-title":"The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale","volume":"20","author":"Labus","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2026.04.008_bib24","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"key":"10.1053\/j.gastro.2026.04.008_bib25","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2036.1997.142318000.x","article-title":"The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress","volume":"11","author":"Francis","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2026.04.008_bib26","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3109\/00365529709011203","article-title":"Stool form scale as a useful guide to intestinal transit time","volume":"32","author":"Lewis","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.04.008_bib27","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1023\/B:DDAS.0000020506.84248.f9","article-title":"IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior","volume":"49","author":"Minderhoud","year":"2004","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2026.04.008_bib28","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0002-9270(01)04037-0","article-title":"Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors","volume":"97","author":"Simren","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.04.008_bib29","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1053\/j.gastro.2024.03.034","article-title":"AGA clinical practice update on pain management in inflammatory bowel disease: commentary","volume":"166","author":"Keefer","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.04.008_bib30","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1016\/S0140-6736(17)32641-7","article-title":"Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial","volume":"390","author":"Colombel","year":"2017","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2026.04.008_bib31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cgh.2019.04.012","article-title":"Development and validation of the mucosal inflammation noninvasive index for pediatric Crohn's disease","volume":"18","author":"Cozijnsen","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.04.008_bib32","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1053\/j.gastro.2022.12.007","article-title":"AGA clinical practice guideline on the role of biomarkers for the management of ulcerative colitis","volume":"164","author":"Singh","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.04.008_bib33","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1053\/j.gastro.2023.09.029","article-title":"AGA clinical practice guideline on the role of biomarkers for the management of Crohn's disease","volume":"165","author":"Ananthakrishnan","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.04.008_bib34","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.3390\/jcm13113030","article-title":"The diagnostic utility of biochemical markers and intestinal ultrasound compared with endoscopy in patients with Crohn's disease and ulcerative colitis: a systemic review and meta-analysis","volume":"13","author":"Huynh","year":"2024","journal-title":"J Clin Med"},{"key":"10.1053\/j.gastro.2026.04.008_bib35","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/ajg.2015.120","article-title":"C-reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: a systematic review and meta-analysis","volume":"110","author":"Mosli","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.04.008_bib36","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/MEG.0000000000002473","article-title":"Oral omeprazole and diclofenac intake is associated with increased faecal calprotectin levels: a randomised open-label clinical trial","volume":"35","author":"Rendek","year":"2023","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.04.008_bib37","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ajg.2015.6","article-title":"A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS","volume":"110","author":"Menees","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.04.008_bib38","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1053\/j.gastro.2015.01.026","article-title":"Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery","volume":"148","author":"Wright","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.04.008_bib39","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.cgh.2024.06.048","article-title":"AGA clinical practice update on endoscopic scoring systems in inflammatory bowel disease: commentary","volume":"22","author":"Buchner","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.04.008_bib40","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/gutjnl-2011-300486","article-title":"Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)","volume":"61","author":"Travis","year":"2012","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2026.04.008_bib41","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.04.008_bib42","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3109\/00365529108998594","article-title":"Ispaghula husk may relieve gastrointestinal symptoms in ulcerative colitis in remission","volume":"26","author":"Hallert","year":"1991","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.04.008_bib43","article-title":"Oat bran increased fecal butyrate and prevented gastrointestinal symptoms in patients with quiescent ulcerative colitis-randomized controlled trial","volume":"2","author":"Nyman","year":"2020","journal-title":"Crohns Colitis 360"},{"key":"10.1053\/j.gastro.2026.04.008_bib44","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1572-0241.1999.872_a.x","article-title":"Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU)","volume":"94","author":"Fernandez-Banares","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.04.008_bib45","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1365-2036.2007.03288.x","article-title":"Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin","volume":"25","author":"Casellas","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2026.04.008_bib46","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1136\/gut.2010.232025","article-title":"Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease","volume":"60","author":"Benjamin","year":"2011","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2026.04.008_bib47","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.3748\/wjg.v23.i18.3356","article-title":"Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease","volume":"23","author":"Pedersen","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.04.008_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2016.22","article-title":"Consistent prebiotic effect on gut microbiota with altered FODMAP intake in patients with Crohn's disease: a randomised, controlled cross-over trial of well-defined diets","volume":"7","author":"Halmos","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1053\/j.gastro.2026.04.008_bib49","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1053\/j.gastro.2019.09.024","article-title":"Effects of low FODMAP diet on symptoms, fecal microbiome, and markers of inflammation in patients with quiescent inflammatory bowel disease in a randomized trial","volume":"158","author":"Cox","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.04.008_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/S1590-8658(19)30446-3","article-title":"P.06.16 Low- versus high-FODMAPs diet in controlling residual abdominal symptoms in inflammatory bowel disease patients: a randomized study with crossing over","volume":"51","author":"Tapete","year":"2019","journal-title":"Dig Liver Dis"},{"key":"10.1053\/j.gastro.2026.04.008_bib51","doi-asserted-by":"crossref","first-page":"S-575","DOI":"10.1016\/S0016-5085(19)38332-5","article-title":"Su1593\u2014Low Fodmaps diet improves functional gastrointestinal symptoms in patients with Crohn disease. A randomized controlled cross-over trial of well-defined diets","volume":"156","author":"Paolini","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.04.008_bib52","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1136\/gutjnl-2021-325214","article-title":"Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis","volume":"71","author":"Black","year":"2022","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2026.04.008_bib53","doi-asserted-by":"crossref","first-page":"6882","DOI":"10.3390\/jcm11236882","article-title":"Efficacy of serotonin type 3 receptor antagonist ramosetron on diarrhea-predominant irritable bowel syndrome (IBS-D)-like symptoms in patients with quiescent inflammatory bowel disease: a randomized, double-blind, placebo-controlled trial","volume":"11","author":"Tomita","year":"2022","journal-title":"J Clin Med"},{"key":"10.1053\/j.gastro.2026.04.008_bib54","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000024059","article-title":"Does rifaximin offer any promise in Crohn's disease in remission and concurrent irritable bowel syndrome-like symptoms?","volume":"100","author":"Tocia","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.gastro.2026.04.008_bib55","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/MCG.0000000000000049","article-title":"Tricyclic antidepressants for management of residual symptoms in inflammatory bowel disease","volume":"48","author":"Iskandar","year":"2014","journal-title":"J Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2026.04.008_bib56","article-title":"Unveiling the efficacy of paroxetine and gabapentin in ulcerative colitis patients in remission with co-existing IBS-like symptoms: a single-blinded randomized clinical trial","volume":"11","author":"Safaei","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"10.1053\/j.gastro.2026.04.008_bib57","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1001\/jamapediatrics.2022.0313","article-title":"Psychosocial interventions for the treatment of functional abdominal pain disorders in children: a systematic review and meta-analysis","volume":"176","author":"Gordon","year":"2022","journal-title":"JAMA Pediatr"},{"key":"10.1053\/j.gastro.2026.04.008_bib58","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1053\/j.gastro.2021.09.015","article-title":"A Rome Working Team report on brain-gut behavior therapies for disorders of gut-brain interaction","volume":"162","author":"Keefer","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.04.008_bib59","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S2468-1253(23)00186-3","article-title":"Efficacy of psychological therapies in people with inflammatory bowel disease: a systematic review and meta-analysis","volume":"8","author":"Riggott","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.04.008_bib60","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1053\/j.gastro.2021.07.037","article-title":"A review of the evidence and recommendations on communication skills and the patient-provider relationship: a Rome Foundation Working Team Report","volume":"161","author":"Drossman","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.04.008_bib61","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1053\/j.gastro.2024.05.010","article-title":"Effect of brain-gut behavioral treatments on abdominal pain in irritable bowel syndrome: systematic review and network meta-analysis","volume":"167","author":"Goodoory","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.04.008_bib62","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1093\/ibd\/izaf047","article-title":"Prevalence of irritable bowel syndrome based on Rome IV criteria in patients in biochemical and endoscopic remission from newly diagnosed inflammatory bowel disease: one- and three-year results (the IBSEN III Cohort)","volume":"31","author":"Olsen","year":"2025","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2026.04.008_bib63","doi-asserted-by":"crossref","first-page":"612","DOI":"10.5056\/jnm20151","article-title":"A pilot study of clinical evaluation and formation mechanism of irritable bowel syndrome-like symptoms in inflammatory bowel disease patients in remission","volume":"27","author":"Wang","year":"2021","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2026.04.008_bib64","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3109\/00365521.2011.579156","article-title":"Symptoms in patients with ulcerative colitis in remission are associated with visceral hypersensitivity and mast cell activity","volume":"46","author":"van Hoboken","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.04.008_bib65","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/gutjnl-2012-304066","article-title":"Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation","volume":"63","author":"Vivinus-Nebot","year":"2014","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2026.04.008_bib66","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/j.gastro.2003.11.055","article-title":"Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome","volume":"126","author":"Barbara","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.04.008_bib67","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cgh.2020.03.044","article-title":"Persistent diarrhea in patients with crohn's disease after mucosal healing is associated with lower diversity of the intestinal microbiome and increased dysbiosis","volume":"19","author":"Boland","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.04.008_bib68","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.cgh.2020.03.013","article-title":"Alterations in fecal microbiomes and serum metabolomes of fatigued patients with quiescent inflammatory bowel diseases","volume":"19","author":"Borren","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.04.008_bib69","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1053\/j.gastro.2025.05.014","article-title":"A practical guide to incorporating a psychologist into a gastroenterology practice","volume":"169","author":"Salwen-Deremer","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.04.008_bib70","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cgh.2023.09.013","article-title":"Development and current state of digital therapeutics for irritable bowel syndrome","volume":"22","author":"Brenner","year":"2024","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508526067582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508526067582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:10:37Z","timestamp":1793754637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508526067582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0016508526067582"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2026.04.008","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommendations for the Evaluation and Management of Inflammatory Bowel Disease With Irritable Bowel Syndrome\u2013Like Symptoms: A Joint Rome Foundation and International Organization for the Study of IBD (IOIBD) Consensus","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2026.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2026 Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}]}}